Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Demonstration of. cap alpha. /sub 2/-adrenergic receptors in rat pancreatic islets using radioligand binding

Journal Article · · Proc. Soc. Exp. Biol. Med.; (United States)

The type of the ..cap alpha..-adrenergic receptors on rat pancreatic islet cells was characterized directly using specific radioligands and displacement agonists and antagonists. Scatchard plots for binding of (/sup 3/H)clonidine (..cap alpha../sub 2/-agonist) revealed a dissociation constant, K/sub d/ of 0.542 +/- 0.1 nM and density of binding sites (B/sub max/) of 50.4 +/- 3.6 fmole/mg protein. Similar values were obtained with (/sup 3/H)dihydroergocryptine (antagonist). The various agonists displaced (/sup 3/H)clonidine with the following order of potency: clonidine > epinephrine approx. = norepinephrine > isoproterenol. Yohimbine, the ..cap alpha../sub 2/-antagonist, was very effective in displacing (/sup 3/H)clonidine, whereas the ..cap alpha../sub 1/-antagonist, prazosin, was much less effective. The data indicate that the ..cap alpha..-adrenergic receptors on rat pancreatic islets are of the ..cap alpha../sub 2/ subtype.

Research Organization:
New York Univ. School of Medicine, NY
OSTI ID:
6438020
Journal Information:
Proc. Soc. Exp. Biol. Med.; (United States), Journal Name: Proc. Soc. Exp. Biol. Med.; (United States) Vol. 171:2; ISSN PSEBA
Country of Publication:
United States
Language:
English